News

Arch Chemicals has appointed three new members to its senior management team. The individuals are assuming the operational responsibilities that had previously been managed by the company’s former

EnWave has announced that it has dried three different antibodies in the company’s prototype freezeREV vial dehydration technology. Results from the study showed no detectable visual difference between

Eisai has announced that it has reached an agreement with Pfizer regarding the strategic alliance for the Alzheimer’s Disease treatment, Aricept (donepezil hydrochloride). Reportedly Eisai and Pfizer have

Galapagos has announced that its service division, BioFocus DPI, has initiated a drug discovery collaboration with Schering-Plough Research Institute (SPRI). As per the agreement, BioFocus DPI would perform

A phase III clinical trial involving more than 16,000 adult volunteers in Thailand has demonstrated that an investigational HIV vaccine regimen was safe and effective in preventing HIV

Cephalon has announced that the FDA has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL (armodafinil) tablets [C-IV], which was filed in June

GeoVax Labs has announced the partial success in the recently completed phase 3 trial in Thailand of a candidate HIV/AIDS vaccine owned by Sanofi-Aventis and Global Solutions for

Reportedly, the US and Chinese governments have approved H1N1 vaccines for use, which will begin next month. The UK government has also reported that the immunisation program is

GlaxoSmithKline has engaged Lazard and Co. with an intention to expand in India. Lazard and Co. will evaluate potential acquisitions in Inida. GSK is reportedly more interested in